How big is the specialty generics market?

The specialty generics market size was estimated at USD 70.19 billion in 2022 and is expected to surpass around USD 180.41billion by 2032

What is the specialty generics market growth?

The global specialty generics market is expected to witness a compound annual growth rate of 9.9% from 2023 to 2032

What are the factors driving the specialty generics market?

The major factors driving market growth are the rising number of off-patent specialty drugs, increasing demand for low-cost specialty generics drugs, increasing prevalence of chronic disease, and increasing emphasis to cut down healthcare expenditure.

Who are the key players in specialty generics market?

Some of the key players in the specialty generics market are Teva Pharmaceutical Industries Ltd; Sun Pharmaceutical Industries Ltd; Mallinckrodt; Viatris, Inc.; Fresenius Kabi Brasil Ltda; STADA Arzneimittel AG; and Novartis AG.

Specialty Generics Market Size, Share & Trends Analysis By Type (Injectables, Oral Drugs), By Application (Oncology, Inflammatory Conditions, Hepatitis C), By End-use (Specialty, Retail), By Region, and Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Report Details

Report Code:6774
Category:Healthcare
No. of Pages:150+
Format:PDF/PPT/Excel
Published:August 2023
Historical Year:2021-2023
Base Year:2024
Estimated Year:2025-2034

Get a Sample

Proceed To Buy

Global Deep Dive Analysis

USD 4500

Single Region (NA,EU,APAC,LA,MEA)

USD 3900

Databook

USD 1900

Competitive Intelligence

USD 1200

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others

Ask To Expert